65289 20200609132535.0 doi 10.1007/s12094-017-1807-y sideral 104275 ART-2017-104275 eng Losa, F. SEOM clinical guideline on unknown primary cancer (2017) 2017 Access copy available to the general public Unrestricted Cancer of unknown primary site is a histologically confirmed cancer that manifests in advanced stage, with no identifiable primary site following standard diagnostic procedures. Patients are initially categorized based on the findings of the initial biopsy: adenocarcinoma, squamous-cell carcinoma, neuroendocrine carcinoma, and poorly differentiated carcinoma. Appropriate patient management requires understanding several clinical and pathological features that aid in identifying several subsets of patients with more responsive tumors. info:eu-repo/semantics/openAccess by http://creativecommons.org/licenses/by/3.0/es/ 2.392 2017 ONCOLOGY 156 / 223 = 0.7 2017 Q3 T3 0.819 2017 Medicine (miscellaneous) 2017 Q2 Oncology 2017 Q2 Cancer Research 2017 Q3 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Soler, G. Casado, A. Estival, A. Fernández, I. Giménez, S. Longo, F. (orcid)0000-0002-8026-7391 Pazo-Cid, R. Salgado, J. Seguí, M.Á. 20 (2017), 89 – 96 Clin. transl. oncol. Clinical and Translational Oncology 1699-048X 666683 http://zaguan.unizar.es/record/65289/files/texto_completo.pdf Versión publicada 54499 http://zaguan.unizar.es/record/65289/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:65289 articulos driver 2020-06-09-13:22:50 ARTICLE